Top Story

Beta-blockers failed to reduce mortality in patients with HF, AF

October 1, 2014

BARCELONA, Spain — Results of a meta-analysis demonstrate that beta-blockers reduced all-cause mortality in patients with HF and sinus rhythm, but not in those with HF and atrial fibrillation.

Researchers analyzed individual patient data from 10 randomized controlled trials comparing beta-blockers with placebo in patients with HF. The data were simultaneously presented at ESC Congress and published in The Lancet.

Meeting News Coverage

STAR-AF 2: Pulmonary vein isolation alone achieved successful outcomes

October 1, 2014
BARCELONA, Spain — In patients with persistent atrial fibrillation, pulmonary vein isolation alone resulted in successful outcomes without the need for additional…
figure

Medical societies express concern as CMS publishes first wave of payment data

September 30, 2014
CMS has come under criticism today for the release of its first batch of Open Payments System data. According to some medical societies, the data are inaccurate and…
Meeting News Coverage

ISAR-CLOSURE: Vascular closure devices noninferior to manual compression in transfemoral coronary angiography

September 30, 2014
WASHINGTON — In patients undergoing transfemoral coronary angiography, vascular closure devices were noninferior to manual compression for vascular access site…
More News Headlines »
CME
figure

Managing Acute Ischemic Stroke in the Emergency Department: Two Decades of Progress

This activity is supported by an educational grant from Genentech.

According to the American Heart Association Heart Disease and Stroke Statistics 2013 Update, approximately 795,000…
More »
Meeting News Coverage Video
figure

Srihari S. Naidu, MD: Percutaneous VADs may fill a ‘gap’ in HF therapy

September 29, 2014
LAS VEGAS — In this video, Srihari S. Naidu, MD, director of the cardiac catheterization lab at Winthrow…
More »
CME
figure

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »